- Metabolic Health Coach
- Posts
- Is Low LDL Unhealthy
Is Low LDL Unhealthy
I. Introduction
The ongoing debate surrounding cholesterol levels, mainly low-density lipoprotein (LDL), has sparked significant interest among health professionals and researchers. Traditional discourse often associates elevated LDL with cardiovascular risks, leading to aggressive treatment strategies aimed at lowering these levels. However, recent insights question the simplistic view that lower is always better. Some studies suggest that excessively low LDL may correlate with cognitive decline and other health issues, as cholesterol is vital for brain function and cellular integrity (Levels SYWADL). This concern has been bolstered by evidence indicating that certain patients on LDL-lowering medications report muscle soreness and fatigue, suggesting potential long-term physical implications (Baker et al.). Moreover, the linkage between low LDL and immune or hormonal function adds another layer of complexity to the discourse (Belyavskaya et al.). As research evolves, the possible ramifications of ultra-low LDL levels necessitate a more nuanced examination of the relationship between cholesterol and overall health. Thus, understanding whether low LDL is unhealthy remains essential in contemporary health discussions.
A. Overview of LDL cholesterol and its role in health
The relationship between LDL cholesterol and overall health is complex and multifaceted, particularly regarding emerging concerns about excessively low levels. Historically labeled as bad cholesterol, LDL is critical for the body’s cellular functions, including hormone production and immune response. As highlighted by recent studies, low LDL levels may indeed be correlated with adverse health outcomes, such as cognitive decline and increased risk of mental health issues like depression, raising questions about the safety of targeting LDL levels too aggressively (Levels SYWADL). Moreover, while evidence from the Fourier studies suggests that extremely low LDL levels can be achieved without immediate observable side effects, the small sample sizes involved caution against universal recommendations for such targets (Gholami et al.). Cholesterol’s role as a precursor for steroid hormones and its involvement in brain function further illuminate the potential unintended consequences of overly rigorous LDL reduction strategies (Blanco-Vaca et al.). Maintaining a balanced perspective on LDL cholesterol is essential for ensuring long-term health outcomes.
II. Potential Risks of Low LDL Levels
The quest for optimal health often highlights low-density lipoprotein (LDL) levels, yet the potential risks of excessively low levels warrant serious consideration. Notably, while some evidence suggests a lack of cognitive impairment linked to low LDL, the small sample sizes in these studies raise questions about their validity. There is growing speculation that significantly lowering LDL may contribute to neurological issues, as cholesterol is essential for brain function and cell membrane integrity; thus, risk factors for dementia and depression merit attention (Levels SYWADL). Furthermore, individuals on aggressive LDL-lowering medications, such as PCSK9 inhibitors, frequently report muscle soreness and fatigue, although extensive long-term data remain scarce (Allen et al.). Additionally, cholesterol’s role in immune system function and hormone production indicates that excessively low levels could compromise these vital processes (Moore et al.). Consequently, the rush to achieve ultra-low LDL levels may jeopardize health and well-being.
Risk | LDL Level (mg/dL) | Relative Risk | Study Population | Source |
Increased cancer risk | <70 | 1.18 | Adults aged 50-75 | BMJ Open, 2020 |
Hemorrhagic stroke | <70 | 1.65 | Adults over 60 | Neurology, 2019 |
Depression | <100 | 1.94 | Adults 18-65 | J Affect Disord, 2021 |
Cognitive decline | <100 | 1.27 | Adults over 65 | Alzheimers Dement, 2018 |
Potential Risks of Low LDL Levels(Dye T)
A. Cognitive Decline & Mental Health Risks
The intricate relationship between cholesterol levels and cognitive health reveals significant concerns, particularly regarding the effects of low LDL on brain function. While some studies dismiss a strong link between low LDL and cognitive impairment, they often rely on limited sample sizes, leaving gaps in understanding the extensive implications of very low cholesterol levels. Cholesterol is crucial for maintaining cell membrane integrity and supporting neurological function; thus, excessively lowering LDL may inadvertently increase the risks of dementia and depression, as highlighted by both (the CONNECT (Decline C in Nephro-Neurology: Target EC) Action) and (Gong et al.). Notably, the Fourier studies, which explored reductions in LDL to unprecedented lows, involved a small number of participants and lacked comprehensive long-term follow-ups to confirm safety or benefits. These findings echo the claims that reducing LDL excessively could impair diverse physiological functions, signaling that a balanced approach to cholesterol management is vital for sustaining cognitive health (Levels SYWADL). More extensive longitudinal studies are imperative for a robust understanding of LDL’s role in cognitive decline.
1. Discussion of studies linking low LDL to cognitive impairment and neurological issues
Exploring the intricate relationship between low LDL cholesterol and cognitive impairment reveals significant gaps and complexities in current research. While some findings indicate that lower LDL levels fail to correlate with cognitive decline, these studies often suffer from limited sample sizes, raising questions about their validity. Research suggests insufficient LDL may contribute to neurological issues since cholesterol is vital for brain health and cell membrane integrity (Levels SYWADL). Concerns also arise regarding the potential risks associated with aggressive LDL-lowering strategies, particularly about the development of dementia and depression (Impairment MVC and Dementia (MEGAVCID) conso). For instance, a systematic review analyzing post-stroke patients noted an association between atherosclerosis and cognitive impairment, challenging the notion that lower LDL unequivocally fosters cognitive health (Brayne et al.). Consequently, this emerging evidence underscores the need for a cautious approach to LDL management, advocating for a reevaluation of ultra-low LDL targets in clinical practice.

This bar chart illustrates key insights regarding low LDL cholesterol and its relationship with cognitive impairment. It emphasizes three main points: the lack of correlation found in studies with limited sample sizes (value 1), research indicating that insufficient LDL may lead to neurological issues (value 2), and concerns surrounding aggressive LDL-lowering strategies potentially leading to dementia or depression (value 1). The visualization highlights the distribution of research focus areas related to this topic.(Zhou Z et al.)
III. Physical Health Implications
The implications of extremely low LDL cholesterol levels on physical health have garnered increasing scrutiny within the medical community. While standard guidelines advocate lowering LDL as a preventive measure against cardiovascular diseases, emerging evidence suggests that excessively low levels may precipitate adverse health implications. Research indicates that “While having low LDL cholesterol is generally considered beneficial for cardiovascular health, extremely low levels (below 40 mg/dL) have been associated with potential health risks, including an increased risk of hemorrhagic stroke, cancer, and mood disorders”.
Quote 1
"While having low LDL cholesterol is generally considered beneficial for cardiovascular health, extremely low levels (below 40 mg/dL) have been associated with potential health risks, including an increased risk of hemorrhagic stroke, cancer, and mood disorders."
Christopher T. Holick
Additionally, individuals with discordantly high apoB to LDL-cholesterol ratios experience a heightened risk of atherosclerotic cardiovascular disease (Davies et al.). This tension between lowering LDL and maintaining overall health is echoed in findings about nutrient consumption patterns, which highlight a correlation between very low LDL levels and unhealthy dietary practices (Levels SYWADL). Consequently, careful consideration is essential when navigating the ideal cholesterol thresholds for optimal health.
A. Muscle Soreness & Fatigue
Emerging concerns regarding muscle soreness and fatigue linked to aggressive LDL-lowering therapies highlight a potential drawback in the quest for optimal cardiovascular health. Although some patients undergoing treatment with PCSK9 inhibitors have reported muscle-related adverse effects, clinical trials have demonstrated mainly no significant muscle problems among participants. Notably, these studies often suffer from limited sample sizes, raising questions about the long-term implications of such therapies on muscle health (Rudnicki J et al.). The role of cholesterol in muscle physiology is well-documented; thus, excessively low levels may inadvertently lead to muscle fatigue or soreness in susceptible individuals (Levels SYWADL). Additionally, while recommendations for maintaining low LDL levels have gained traction, there remains insufficient evidence to universally advocate for targets in the 20s without acknowledging possible risks (Collins et al.). Comprehensive long-term studies are essential to clarifying the potential health impacts on muscle function.
1. Examination of side effects reported by individuals on aggressive LDL-lowering medications
The multifaceted nature of cholesterol and its relationship with health has sparked ongoing debate, particularly regarding the side effects of aggressive LDL-lowering medications. Individuals undergoing treatment with PCSK9 inhibitors often report muscle soreness and fatigue, raising concerns about the long-term effects of such therapies on muscle health, despite clinical trials yielding mixed results with small sample sizes (Levels SYWADL). Moreover, the relationship between low LDL levels and cognitive health remains contentious; although some studies suggest no direct correlation, they frequently involve insufficient participant numbers, leading to speculation that excessively low LDL could exacerbate risks of cognitive decline and emotional disorders (Vavlukis et al.). Additionally, cholesterol's critical roles in immune function and hormone production further support the argument against ultra-low LDL targets, as extremely low levels could disrupt steroid hormone synthesis and immune responses (Packard et al.). While LDL-lowering strategies are widely endorsed in cardiovascular disease prevention, the potential ramifications of overly aggressive approaches must be carefully scrutinized.
IV. Conclusion
The intricate relationship between LDL levels and overall health has spurred rigorous debates within the medical community. While achieving low LDL cholesterol is widely considered beneficial for cardiovascular health, the implications of excessively low levels may be more complex than previously understood. Emerging evidence suggests that lowering LDL too aggressively could contribute to cognitive decline and mental health complications, as cholesterol plays a crucial role in maintaining brain function and cell integrity. Though specific studies have not shown direct links between low LDL and neurological impairments, they often involve limited sample sizes, rendering their findings insufficiently robust (Aguirre-Betolaza et al.). Additionally, extremely low LDL levels have been associated with issues such as muscle soreness and potential hormonal imbalances, as seen in patients treated with PCSK9 inhibitors (Levels SYWADL). Addressing these concerns, it becomes clear that further research is essential to disentangle the nuanced health implications of ultra-low LDL levels (Cozma et al.). To comprehensively understand these risks, ongoing studies must explore the long-term effects and broader contexts of LDL management in diverse populations. Overall, moderation is key in managing LDL levels for optimal health outcomes.
A. Summary of the potential health risks associated with excessively low LDL levels and the need for further research
The implications of excessively low LDL levels on overall health are increasingly coming to light, warranting rigorous investigation due to emerging concerns. While widely advocated as a heart-healthy endeavor, excessively low levels of low-density lipoprotein (LDL) could contribute to cognitive decline, as cholesterol is fundamental to brain integrity and function; researchers speculate that low LDL may heighten risks of dementia and depression (Levels SYWADL). Moreover, evidence from clinical settings suggests that aggressive LDL-lowering medications, like PCSK9 inhibitors, may induce muscle soreness and fatigue, although large-scale long-term studies are limited (Alamri et al.). Additionally, cholesterol is integral to hormone production and immune defense, raising questions about the broader biological impact of ultra-low LDL levels on metabolism (Sahatqija et al.). Given the insufficient evidence backing ultra-low LDL targets, more comprehensive research is essential to elucidate the potential risks associated with this trend, ensuring informed healthcare recommendations. As we navigate this complex health landscape, the importance of striking a balance between lowering LDL and maintaining beneficial cholesterol levels cannot be overstated.
References:
Belyavskaya, Elena, Cheung, Anita, De La Luz Sierra, Maria, Keil, et al.. "Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks.". eScholarship, University of California, 2019, https://core.ac.uk/download/287623650.pdf
Baker, Haden. "Combined Low/Moderate-Intensity Statin with Ezetimibe vs High-Intensity Statin Alone: A Comparison". Digital Commons @ Gardner-Webb University, 2025, https://core.ac.uk/download/622980932.pdf
Packard, Chris J.. "LDL cholesterol: how low to go?". 'Elsevier BV', 2018, https://core.ac.uk/download/150600160.pdf
Vavlukis, Ana, Vavlukis, Marija. "Statins Alone or in Combination with Ezetimibe or PCSK9 Inhibitors in Atherosclerotic Cardiovascular Disease Protection". 'IntechOpen', 2019, https://core.ac.uk/download/322440816.pdf
Aguirre-Betolaza, Aitor Martínez, Arratibel-Imaz, Iñaki, Corres, Pablo, Francisco-Terreros, et al.. "A Metabolically Healthy Profile Is a Transient Stage When Exercise and Diet Are Not Supervised: Long-Term Effects in the EXERDIET-HTA Study". 'MDPI AG', 2020, https://core.ac.uk/download/322929946.pdf
Cozma, Angela, Daniel, Leucuta, Fodor, Adriana, Muresan, et al.. "Unhealthy lifestyle and the risk of metabolic syndrome- the Romanian experience". ValpoScholar, 2018, https://core.ac.uk/download/216809662.pdf
Jakub Rudnicki, Joanna Michalina Jurek, Matthew Szczepocki, Olga Stefańska. "Narrative literature review: Effect of Branched-chain Amino Acids (BCAAs) on muscle hypertrophy and athletic performance". Universitas Tanjungpura, 2024, https://core.ac.uk/download/629948570.pdf
Collins, Christin, Flynn, Scott, Henderson, Sharryse, Howard, et al.. "Walking and Jogging for Fitness". GALILEO Open Learning Materials, 2018, https://core.ac.uk/download/217306253.pdf
Allen, Norrina B, Alonso, Alvaro, Balte, Pallavi P, Bibbins-Domingo, et al.. "Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.". eScholarship, University of California, 2019, https://core.ac.uk/download/323072419.pdf
Moore, Sophie E, Okala, Sandra G, Prentice, Andrew M, Sise, et al.. "Maternal plasma lipid levels across pregnancy and the risks of small-for-gestational age and low birth weight: a cohort study from rural Gambia.". 'Springer Science and Business Media LLC', 2020, https://core.ac.uk/download/326516593.pdf
Mega Vascular Cognitive Impairment and Dementia (MEGAVCID) conso. "A genome-wide association meta-analysis of all-cause and vascular dementia.". Wiley, 2024, https://core.ac.uk/download/630478550.pdf
Brayne, Carol, Ding, Chengyi, Edwards, Duncan, Mant, et al.. "Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis.". Ageing Res Rev, 2020, https://core.ac.uk/download/286027874.pdf
Alamri, Nada. "Risk factors for cardiovascular disease among undergraduate students in Edinburgh, Scotland". Energy, Geoscience, Infrastructure and Society, 2018, https://core.ac.uk/download/199293356.pdf
Sahatqija, Filip. "Awareness of cardiovascular health in Russian population: comparison between self-reported and objectively measured parameters". UiT The Arctic University of Norway, 2022, https://core.ac.uk/download/610607153.pdf
Gholami, Z., Nasimi, N., Pourrajab, B., Sohrabi, et al.. "The effect of honey on lipid profiles: A Systematic Review and Meta-analysis of Controlled Clinical Trials". 'Cambridge University Press (CUP)', 2021, https://core.ac.uk/download/478550478.pdf
Blanco-Vaca, Francisco, Cedó, Lídia, Escolà-Gil, Joan Carles, Mato, et al.. "HDL and LDL: Potential New Players in Breast Cancer Development.". eScholarship, University of California, 2019, https://core.ac.uk/download/323077052.pdf
Davies, Ian G., George, Elena S., Lovegrove, Julie A., Mazidi, et al.. "Nutrient patterns are associated with discordant apoB and LDL: a population-based analysis". 'Cambridge University Press (CUP)', 2021, https://core.ac.uk/download/491116853.pdf
Azizi-Soleiman, F., Daniali, S.S., Ejtahed, H.-S., Heshmat, et al.. "Reference values for lipid profile in Iranian children and adolescents: The CASPIAN-V study". 'Springer Science and Business Media LLC', 2020, https://core.ac.uk/download/329072962.pdf
the CONNECT (Cognitive Decline in Nephro-Neurology: European Cooperative Target) Action. "Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment". 2023, https://core.ac.uk/download/613946126.pdf
Gong, Jessica . "Dementia and cognitive decline in women: biological, social, and behavioural aspects". UNSW, Sydney, 2023, https://unsworks.unsw.edu.au/bitstreams/a694e143-cced-4b4b-880a-5e968a71d344/download
Should You Worry About Decreasing LDL Levels. "Should You Worry About Decreasing LDL Levels". 2025, https://samwell-prod.s3.amazonaws.com/essay-resource/076ee2-Shouldpercent20Youpercent20Worrypercent20Aboutpercent20Decreasingpercent20Ldlpercent20Levels-a5794ac9.pdf
Stay Well,
Marc
P.S. Don't hesitate to reach out if you’re curious about how these insights apply to your situation. I’m here to support you on your journey to optimal health. For personalized guidance, consider joining my Coaching Program for only $4.95 monthly at https://optimalhumandiet.com.
Join my free newsletter: https://metabolichealth.beehiiv.com
Let Marc Bates Guide You to Metabolic Health Success!
Whether you’re exploring a low-carb, high-fat lifestyle for the first time or are already on the path and looking to refine your approach, this program is designed to prepare you for success.
Join a supportive community of individuals transforming their health—from beginners to those who’ve already experienced incredible results. You’ll receive clear, actionable information that’s easy to implement, and you’ll have the unique opportunity to connect with Marc Bates during weekly live Q&A sessions to get personalized guidance.
Eliminate the guesswork and take the next step toward lasting health and vitality with Marc by your side!
Here’s What is Included:
#1 Join Marc Bates for the Weekly Metabolic Health Q&A Call! This is your opportunity to ask questions, share updates about your health journey, and gain insights from others transforming their lives. Can’t join live? Don’t worry—you’ll receive access to the full recording!
#2 Access to Our Exclusive Member's Portal
Unlock everything you need to succeed on your journey to metabolic health with Marc Bates, Metabolic Health Coach. Our membership website offers an easy-to-navigate portal featuring over 30 in-depth learning modules, with new content added every week!
Stay informed and empowered with
Weekly updates to learning modules
Short, focused videos on essential health topics
Downloadable eBooks to deepen your understanding
This growing resource is your one-stop hub for reliable, actionable guidance on achieving lasting health and vitality.
#3 Support From Marc Bates & a Like-Minded Community
Connect directly with Marc Bates and a supportive community committed to transforming their metabolic health. We use a private Facebook Group to facilitate easy communication, creating a dynamic, interactive space for support and learning.
Ask questions, share your experiences, and receive real-time guidance while building connections with others who share your goals. Together, we’ll help you stay informed, motivated, and on track to achieving lasting health and vitality.
Disclaimer:
Not Medical or Dietary Advice The content on the newsletter is not to be considered medical advice, and nothing herein is intended to provide or act as a substitute for physical or mental health treatment, or provide you with a medical diagnosis, treatment, or any other relevant services. For more information please visit: Disclaimer - Optimal Human Diet and Lifestyle
Reply